The application of cell-based label-free technology in drug discovery

被引:145
作者
Xi, Biao [1 ]
Yu, Naichen [1 ]
Wang, Xiaobo [1 ]
Xu, Xiao [1 ]
Abassi, Yama A. [1 ]
机构
[1] ACEA Biosciences, Cell Biology and Assay Development, San Diego, CA 92121
关键词
Cell-based; Drug discovery; Impedance; Kinetic; Label-free;
D O I
10.1002/biot.200800020
中图分类号
学科分类号
摘要
Cell-based assays are an important part of the drug discovery process allowing for interrogation of targets and pathways in a more physiological setting compared to biochemical assays. One of the main hurdles in the cell-based assay field is to design sufficiently robust assays with adequate signal to noise parameters while maintaining the inherent physiology of the pathway or target being investigated. Conventional label and reporter-based cell assays may be more prone to artifacts due to considerable manipulation of the cell either by the label or over-expression of targets or reporter proteins. Cell-based label-free technologies preclude the need for cellular labeling or over-expression of reporter proteins, utilizing the inherent morphological and adhesive characteristics of the cell as a physiologically relevant and quantitative readout for various cellular assays. Furthermore, these technologies utilize non-invasive measurements allowing for time resolution and kinetics in the assay. In this article, we have reviewed the various label-free technologies that are being used in drug discovery settings and have focused our discussion on impedance-based label-free technologies and its main applications in drug discovery. © 2008 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.
引用
收藏
页码:484 / 495
页数:11
相关论文
共 66 条
[1]  
Kola I., Landis J., Can the pharmaceutical industry reduce attrition rates?, Nat. Rev. Drug Discov., 3, pp. 711-715, (2004)
[2]  
Horrobin D.F., Modern biomedical research: an internally self‐consistent universe with little contact with medical reality?, Nat. Rev. Drug Discov., 2, pp. 151-154, (2003)
[3]  
Drews J., Strategic trends in the drug industry., Drug Discov. Today, 8, pp. 411-420, (2003)
[4]  
Cooper M.A., Non‐optical screening platforms: the next wave in label‐free screening?, Drug Discov. Today, 11, pp. 1068-1074, (2006)
[5]  
Cooper M.A., Optical biosensors: where next and how soon?, Drug Discov. Today, 11, pp. 1061-1067, (2006)
[6]  
McGuinness R., Impedance‐based cellular assay technologies: recent advances, future promise., Curr. Opin. Pharmacol., 7, pp. 535-540, (2007)
[7]  
Verdonk E., Johnson K., McGuinness R., Leung G., Cellular dielectric spectroscopy: a label‐free comprehensive platform for functional evaluation of endogenous receptors., Assay Drug Dev. Technol., 4, pp. 609-619, (2006)
[8]  
Atienza J.M., Yu N., Wang X., Xu X., Label‐free and real‐time cell‐based kinase assay for screening selective and potent receptor tyrosine kinase inhibitors using microelectronic sensor array., J. Biomol. Screen., 11, pp. 634-643, (2006)
[9]  
Fang Y., Label‐free cell‐based assays with optical biosensors in drug discovery., Assay Drug Dev. Technol., 4, pp. 583-595, (2006)
[10]  
Hug T.S., Biophysical methods for monitoring cell‐substrate interactions in drug discovery., Assay Drug Dev. Technol., 1, pp. 479-488, (2003)